AMLX

26.0100.73%
JB

Justin B. Klee

Co-CEO & Director

Mr. Justin B. Klee co-founded Amylyx Pharmaceuticals, Inc. in 2013 and has been its Co-Chief Executive Officer and Director since January 2014. Mr. Klee served as President of Amylyx Pharmaceuticals, Inc. Mr. Klee has leveraged his extensive experience in neurophysiology and Alzheimer ’s disease research to help build and evaluate Amylyx’s novel platform and therapeutic for neurodegenerative diseases. His research includes work at Brown University and Harvard Medical School. Mr. Klee holds B.Sc. in Neuroscience from Brown University.

Positions